What are the obligations of pharmaceutical companies in a global health emergency?

• Main Authors: Emanuel, EJ, Buchanan, A, Chan, SY, Fabre, C, Halliday, D, Heath, J, Herzog, L, Leland, RJ, McCoy, MS, Norheim, OF, Saenz, C, Schaefer, GO, Tan, KC, Wellman, CH, Wolff, J, Persad, G
• Other Authors: DEAN'S OFFICE (MEDICINE)
• Format: Review
• Published: Elsevier BV 2022
• Subjects: Costs and Cost Analysis; Developing Countries; Drug Industry; Global Health; Humans; Social Responsibility
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/228267
• Institution: National University of Singapore

10.1016/S0140-6736(21)01378-7